documents: FDA-2020-N-1819-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2020-N-1819-0001 | FDA | FDA-2020-N-1819 | Certain Requirements Regarding Prescription Drug Marketing | Proposed Rule | Notice of Proposed Rulemaking (NPRM) | 2022-02-04T05:00:00Z | 2022 | 2 | 2022-02-04T05:00:00Z | 2022-04-06T03:59:59Z | 2022-04-07T01:00:49Z | 2022-01927 | 0 | 0 | 0900006484f54a12 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref